NFKB1 and gastric cancer: Likewise, Manu et al. also reported that simvastatin reduced the proliferation and invasion of human gastric cancer cells (SNU-5, SNU-16, MKN45, and AGS) through inhibition of the NF-κB signaling pathway [24].